Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry.

Publication Type:

Journal Article

Source:

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume 19, Issue 8, p.2023-34 (2010)

Keywords:

2010, Antineoplastic Agents, Center-Authored Paper, Clinical Research Division, Collaborative Data Services Core Facility, Colorectal Neoplasms, Dietary Supplements, Family Health, Female, folic acid, Follow-Up Studies, Health Behavior, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Prevention Center Core Facility, Prognosis, Public Health Sciences Division, Questionnaires, Registries, Research Trials Office Core Facility - Biostatistics Service, Sex Factors, Shared Resources, Specimen Processing Core Facility

Abstract:

Supplement use among cancer patients is high, and folic acid intake in particular may adversely affect the progression of colorectal cancer. Few studies have evaluated the use of folic acid-containing supplements (FAS) and its predictors in colorectal cancer patients.